Search by Drug Name or NDC
NDC 46122-0535-51 Motion Sickness Relief 25 mg/1 Details
Motion Sickness Relief 25 mg/1
Motion Sickness Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Amerisource Bergen. The primary component is MECLIZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
Related Packages: 46122-0535-51Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Meclizine
Product Information
| NDC | 46122-0535 |
|---|---|
| Product ID | 46122-535_440e2e58-5bcc-4ba3-9275-273a7040e457 |
| Associated GPIs | 50200050000310 |
| GCN Sequence Number | 004732 |
| GCN Sequence Number Description | meclizine HCl TABLET 25 MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 18302 |
| HICL Sequence Number | 001975 |
| HICL Sequence Number Description | MECLIZINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Motion Sickness Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Meclizine HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | MECLIZINE HYDROCHLORIDE |
| Labeler Name | Amerisource Bergen |
| Pharmaceutical Class | Antiemetic [EPC], Emesis Suppression [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M009 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 46122-0535-51 (46122053551)
| NDC Package Code | 46122-535-51 |
|---|---|
| Billing NDC | 46122053551 |
| Package | 1 BLISTER PACK in 1 CARTON (46122-535-51) / 8 TABLET in 1 BLISTER PACK |
| Marketing Start Date | 2002-06-24 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.08244 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | MOTION SICKNESS RLF 25 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis